HCPCS code C9062 — Daratumumab hyaluronidase. Status: Deleted. Effective Jan 1, 2021. Source: CMS HCPCS Level II.

C9062

Deleted

Daratumumab hyaluronidase

Injection, daratumumab 10 mg and hyaluronidase-fihj

Code C9062 has been deleted from the HCPCS Level II set.

Termination date: Dec 31, 2020. Claims with a date of service on or after this day will be denied under this code.

No successor code has been identified. Consult the CMS HCPCS Update Summary for guidance.

Category: Outpatient PPS
Section: C-codes: Outpatient PPS
Effective: Jan 1, 2021
Terminated: Dec 31, 2020
Code type: alphanumeric

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2021-Q1
    Daratumumab hyaluronidase
  • Deleted 2020-Q4
    Daratumumab hyaluronidase